[print friendly]

adverse effects of drugs

• Adverse Drug Reactions [show all summaries]
• Allergy and Hayfever [show all summaries]
• Antipsychotic Drugs: Dangerously Overused [show all summaries]
• Arthritis and Inflammation [show all summaries]
• Benign Prostatic Hypertrophy (BPH) [show all summaries]
• Constipation [show all summaries]
• Cough and Cold [show all summaries]
• Depression: When are Drugs Called For And Which Ones Should You Use? [show all summaries]
• Diabetes Prevention and Treatment [show all summaries]
• Diarrhea [show all summaries]
• Dietary and Herbal Supplements [show all summaries]
• Drug-Induced Diseases [show all summaries]
• Elevated Cholesterol Levels [show all summaries]
• Fluoroquinolones [show all summaries]
• High Blood Pressure [show all summaries]
• Hormone Replacement Therapy [show all summaries]
• Migraine Headaches [show all summaries]
• Muscle Relaxants [show all summaries]
• Narcotics [show all summaries]
• Oral Contraceptives [show all summaries]
• Osteoporosis [show all summaries]
• Penicillins and Cephalosporins [show all summaries]
• Salicylates and Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) [show all summaries]
• Sleeping Pills and Tranquilizers [show all summaries]
• Tetracyclines [show all summaries]
• Ulcers and Gastroesophageal Reflux Disease (GERD) [show all summaries]
• Vitamins and Minerals [show all summaries]

• Life-Threatening Liver Toxicity of Avandia Shown in New Public Citizen Research Published in Peer-Reviewed Medical Journal [show all summaries]
• Letter Urging the FDA to Halt its Review of Prasugrel (HRG Publication #1876) [show all summaries]
• Petition to the FDA Requesting Enhanced Warnings for Amitiza (lubiprostone) (HRG Publication #1871) [show all summaries]
• Statement of Dr. Peter Lurie on FDA granting Public Citizen's Petition that Sought to Warn Patients and Doctors about the Dangers of Botulinum Toxin (HRG Publication #1870) [show all summaries]
• Letter to FDA About Safety Concerns with Prasugrel Hydrochloride and Removal of Dr. Sanjay Kaul from Cardiovascular and Renal Drugs Advisory Committee Meeting (HRG Publication #1857) [show all summaries]
• FDA Committee Vote Confirms Darvon’s Risks Outweigh Benefits, Drug Should Be Banned [show all summaries]
• Testimony of Sidney Wolfe Before Food and Drug Administration Advisory Committee on Propoxyphene (DARVON) (HRG Publication #1856) [show all summaries]
• Petition to Immediately Ban Diabetes Drug Rosiglitazone (AVANDIA) (HRG Publication #1848) [show all summaries]
• Testimony before FDA hearing on cough and cold remedies for children (HRG Publication #1845) [show all summaries]
• Comments to FDA Re: Content and Format of Labeling for Human Prescription Drug and Biological Products: Requirements for Pregnancy and Lactation Labeling (HRG Publication #1841) [show all summaries]
• FDA Must Do More to Warn Patients Taking Flouroquinolone Antibiotics of Possible Tendon Ruptures [show all summaries]
• Petition to the FDA to Ban Ortho-Evra (HRG Publication #1840) [show all summaries]
• Article in JAMA: Cell-Free Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death: A Meta-analysis (HRG Publication #1839) [show all summaries]
• Congress Must Act Quickly to Address Growing Crisis At the Food and Drug Administration [show all summaries]
• FDA's Botox Warning Falls Short [show all summaries]
• Stricter Warnings Needed for Botox, Myobloc Injections [show all summaries]
• FDA Neglecting Its Responsibility to Protect Children From Risky, Ineffective Cough and Cold Medicines [show all summaries]
• Drug Companies, FDA Lagged in Warning Public About Zetia, Vytorin [show all summaries]
• Antibiotic Leads to Tendon Ruptures; FDA Ignores Risks [show all summaries]
• Comments on FDA's Draft Guidance for Industry - Drug-Induced Liver Injury: Premarketing Clinical Evaluation (HRG Publication #1833) [show all summaries]
• FDA Should Deny Over-The-Counter Access to Risky Cholesterol Drug [show all summaries]
• Children Under 12 Should Not Be Given Cough, Cold Medications, Public Citizen Tells FDA [show all summaries]
• Diabetes Drug Avandia Should Be Removed From the Market, Public Citizen Tells FDA Advisory Committee [show all summaries]
• European Drug Regulatory Authority Should Remove Arthritis Drug Etoricoxib and Weight Loss Drug Rimonabant From European Market [show all summaries]
• Weight Loss Drug Rimonabant Can Cause Serious Physical and Psychological Harm and Birth Defects, Public Citizen Tells FDA [show all summaries]
• FDA Knew of Avandia’s Dangers Nearly Five Years Ago, Memo Shows [show all summaries]
• Evidence Confirms Public Citizen’s Warnings About the Risks of Popular Diabetes Drug Avandia [show all summaries]
• FDA Should Not Approve Painkiller Dubbed “Offspring of Vioxx” [show all summaries]
• FDA Should Not Have Approved Tegaserod (Zelnorm); Public Citizen Warned of Dangers When Drug Was Considered in 2001 [show all summaries]
• FDA Approval of Over-the-Counter Orlistat Is Reckless [show all summaries]
• Petition to the FDA to Ban Third Generation Oral Contraceptives Containing Desogestrel due to Increased Risk of Venous Thrombosis (HRG Publication #1799) [show all summaries]
• FDA Proposal for Painkiller Warning Is Decades Late [show all summaries]
• Public Citizen Petitions the FDA to Include a Black Box Warning on Fluoroquinolone Antibiotics (HRG Publication #1781) [show all summaries]
• Update on Use of Growth Hormone for Normal Small Children: Discussed on CNN International June 20, 2006 (HRG Publication #1774) [show all summaries]
• Statement Before the Institute of Medicine Committee on Developing Cancer Biomarkers: A Case Study Involving ACF/orlistat (HRG Publication #1773) [show all summaries]
• Supplement to petition to ban diet drug orlistat (XENICAL). Additional information provided about pre-cancerous changes to the colon (HRG Publication #1771) [show all summaries]
• Testimony before FDA Advisory Committee on Rivastigmine (Exelon) for Dementia Associated with Parkinson’s Disease (HRG Publication #1769) [show all summaries]
• Petition to the FDA to Immediately Ban the Antibiotic Gatifloxacin (Tequin) (HRG Publication #1768) [show all summaries]
• Petition to the FDA to immediately remove the diet drug orlistat (XENICAL) from the market (HRG Publication #1764) [show all summaries]
• Petition to FDA to ban all propoxyphene (DARVON) products; prescription painkiller causes many fatalities (HRG Publication #1762) [show all summaries]
• Testimony Before the FDA Advisory Committees on Possible Switch of Orlistat (XENICAL) to OTC Status (HRG Publication #1760) [show all summaries]
• Letter to FDA urging that the diabetes drug muraglitazar (PARGLUVA) not be approved because of an increased risk of serious adverse reactions including death (HRG Publication #1756) [show all summaries]
• Petition to the FDA to require a black box warning for erectile dysfunction drugs (Viagra, Cialis, Levitra) to warn of the potential for irreversible vision loss (HRG Publication #1753) [show all summaries]
• Misleading data analyses in salmeterol (SMART) study (HRG Publication #1752) [show all summaries]
• Testimony before FDA Advisory Committee on new diabetes drug Muraglitazar (PARGLUVA): Risks outweigh the benefits. (HRG Publication #1749) [show all summaries]
• FDA Denial of Public Citizen’s Petition to Ban Meridia Is Misguided (HRG Publication #1748) [show all summaries]
• Drugs and breastfeeding--a letter to the Editor of Australian Prescriber (HRG Publication #1740) [show all summaries]
• Supplement to Petition to the FDA to Withdraw the Lung Cancer Drug gefitinib (Iressa) from the Market (HRG Publication #1739) [show all summaries]
• Bextra Ban a Good Step, But FDA Should Pull Celebrex Too (HRG Publication #1734) [show all summaries]
• Statin-associated rhabdomyolysis (HRG Publication #1733) [show all summaries]
• Petition to the FDA to remove the Attention Deficit drug pemoline (CYLERT) from the market because of liver toxicity (HRG Publication #1731) [show all summaries]
• Statement of Sidney Wolfe, M.D. regarding the FDA's decision to leave Crestor on the market (HRG Publication #1730) [show all summaries]
• Letter to FDA shows that Crestor has higher rates of rhabdomyolysis compared to other statins (HRG Publication #1729) [show all summaries]
• Painkillers and Terrorism. Letter to the Editor of the New York Times on Cox 2 Painkillers (HRG Publication #1727) [show all summaries]
• Testimony to FDA on Dangers of Cox-2 Drugs (HRG Publication #1725) [show all summaries]
• Congressional Testimony by Sidney Wolfe M.D. on Current Issues Related to Medical Liability Reform (HRG Publication #1724) [show all summaries]
• Letter to FDA revealing heart dangers in an unpublished clinical trial of Celebrex (HRG Publication #1721) [show all summaries]
• Petition to remove the Cox-2 Inhibitors Celecoxcib (CELEBREX) and Valdecoxcib (BEXTRA) From the Market (HRG Publication #1720) [show all summaries]
• The Serious Public Health Dangers of Prescription-to-OTC Switch of Lovastatin: Testimony by Sidney M. Wolfe, MD Before the FDA Endocrinologic/Metabolic and Non-Prescription Drugs Advisory Committees (HRG Publication #1719) [show all summaries]
• Testimony Before the FDA Reproductive Health Advisory Committee Concerning the Transdermal Testosterone Patch (HRG Publication #1713) [show all summaries]
• Letter to FDA urging action on misleading CRESTOR advertising by AstraZeneca (HRG Publication #1712) [show all summaries]
• Letter to FDA Renewing Call for Crestor to Be Removed From Market. Rate of Kidney Damage in Crestor Patients Is 75 Times Higher Than in Patients Taking Other Cholesterol Drugs (HRG Publication #1710) [show all summaries]
• Dangers of rosuvastatin identified before and after FDA approval (HRG publication #1699) [show all summaries]
• Vioxx, Other “Super Aspirins” Are Super Disasters – Other Cox-2 Alternatives Have Safety Problems Too (HRG Publication #1707) [show all summaries]
• Testimony before the FDA's Cardiovascular and Renal Drugs Advisory Committee Hearing on Ximelagatran--September 10, 2004 (HRG Publication #1706) [show all summaries]
• Letter to FDA calling for criminal investigation of AstraZeneca because the company illegally delayed submitting reports of serious adverse reactions to cholesterol drug Crestor. (HRG Publication #1703) [show all summaries]
• Letter to NIH Director questioning the propriety of the actions of a senior NIH scientist who was a consultant for AstraZeneca. (HRG Publication #1700) [show all summaries]
• Letter to the FDA urging removal of the cholesterol-lowering drug rosuvastatin (CRESTOR) from the market (HRG Publication #1698) [show all summaries]
• Testimony before FDA advisory committee concerning alosetron (Lotronex) (HRG Publication #1697) [show all summaries]
• Petition to the FDA to remove the cholesterol-lowering drug rosuvastatin (CRESTOR) from the market (HRG Publication #1693) [show all summaries]
• Testimony before FDA Advisory Committee on Accutane. It should be removed from the market and prescribed only under very limited and controlled conditions. (HRG Publication #1691) [show all summaries]
• Supplement to Petition to the FDA to ban the anitidepressant drug nefazadone (SERZONE) (HRG Publication #1681) [show all summaries]
• Petition supplement to FDA outlining the rising number of cardiovascular events associated with the diet drug sibutramine (MERIDIA) (HRG Publication #1675) [show all summaries]
• Statement of Sidney M. Wolfe, MD before the FDA Endocrinologic and Metabolic Drugs Advisory Committee Hearing on Rosuvastatin (HRG Publication #1669) [show all summaries]
• Testimony of Sidney Wolfe, M.D. before Endocrinologic and Metabolic Drugs Advisory Committee concerning the use of growth hormone for idiopathic short stature (HRG Publication 1667a) [show all summaries]
• Petition to the FDA to add a black box warning to the label of the cancer drug IRESSA (HRG Publication #1667) [show all summaries]
• Letter to FDA expressing concerns about the pending approval of the cancer drug gefitinib (IRESSA) (HRG Publication #1665) [show all summaries]
• Article by Sidney Wolfe in Science magazine: Ephedra Scientific Evidence Versus Money/Politics (HRG Publication #1664) [show all summaries]
• Petition to the FDA to Ban the Antidepressant Drug Nefazadone (SERZONE) (HRG Publication #1657) [show all summaries]
• Letter to FDA addressing Dr. Gary Firestein's comments concerning HRG's petition to remove ARAVA from the market (HRG Publication #1644) [show all summaries]
• Testimony Before Senate Governmental Affairs Committee Hearing on Dangers of Ephedra (HRG Publication #1642) [show all summaries]
• Statement on Safety Issues Related to Acetaminophen Before the Nonprescription Drugs Advisory Committee (HRG Publication #1639) [show all summaries]
• Letter to HHS Secretary Tommy Thompson that raises ethical concerns about the “Alzheimer’s Disease Anti-Inflammatory Prevention Trial” (ADAPT) (HRG Publication #1637) [show all summaries]
• Allowing Lotronex Back on the Market Will Endanger Patients (HRG Publication #1622) [show all summaries]
• Letter to HHS urging that criminal charges be brought against Abbott Laboratories for illegally withholding information concerning eight deaths and other adverse effects of the drug sibutramine (MERIDIA) (HRG Publication #1619) [show all summaries]
• Testimony Before FDA Advisory Committee Concerning Alosetron (LOTRONEX) (HRG Publication #1617) [show all summaries]
• Petition to FDA to ban the diet drug sibutramine (MERIDIA) (HRG Publication #1613) [show all summaries]
• Letter urging the FDA to reject drug industry's request for liability disclaimer in its withdrawal of products containing phenylpropanolamine (PPA) (HRG Publication #1596) [show all summaries]
• Petition to the FDA to issue strong warnings about the potential for certain cholesterol-lowering drugs to cause potentially life-threatening muscle damage. (HRG Publication #1588) [show all summaries]
• Statement to the Food and Drug Administration's Endocrinologic and Metabolic Drugs Advisory Committee urging them to not approve the drug teriparatide. (HRG Publication #1585) [show all summaries]
• Testimony before the Food and Drug Administration Endocrine and Metabolic Drugs Advisory Committee Meeting on pramlintide (Symlin), recommending that it not be approved and that no additional clinical trials be done (HRG Publication #1584) [show all summaries]
• Letter to the FDA concerning tegaserod (Zelnorm), for constipation-predominant irritable bowel syndrome, and Novartis' reluctance to use ultrasound monitoring for their clinical trial subjects. (HRG Publication #1582) [show all summaries]
• Letter to the Food and Drug Administration on a study stating a possible mechanism for the induction of ovarian cysts with the use of tegaserod (Zelmac) (HRG Publication #1577) [show all summaries]
• Testimony before the Food and Drug Administration's Cardiovascular and Renal Drugs Advisory Committee on a petition to relabel doxazosin (Cardura). (HRG Publication #1575) [show all summaries]
• Letter to the FDA concerning a memo from their Office of Post-marketing Drug Risk Assessment (OPDRA) that confirms and extends the dangers of the drug Lotronex (alosetron) for irritable bowel syndrome (HRG Publication #1566) [show all summaries]
• Letter to the Food and Drug Administration urging that it not approve tegaserod (Zelmac) because of its highly questionable efficacy and its potential to cause ovarian cysts (HRG Publication #1561) [show all summaries]
• Testimony before the House of Representatives Committee on Government Reform Hearing on Dietary Supplements. (HRG Publication #1560) [show all summaries]
• Testimony before the FDA Arthritis Drugs Advisory Committee on the Nonsteroidal Anti-Inflammatory Drugs Celecoxib and Rofecoxib (HRG Publication #1555) [show all summaries]
• Letter to the National Institute for Clinical Excellence urging it to reconsider recommendations concerning Relenza use among people in the United Kingdom. (HRG Publication #1547) [show all summaries]
• Letter to the Food and Drug Administration updating the number of cases of ischemic coliitis reported in our 8/31/00 petition. (HRG Publication #1544) [show all summaries]
• Testimony before the Food and Drug Administration NonPrescription Drugs Advisory Committee Meeting on Safety Issues of Phenylpropanolamine/PPA. (HRG Publication #1541) [show all summaries]
• Petition to the Food and Drug Administration requesting an immediate ban of all uses of Phenylpropanolamine (PPA) in over-the-counter products. (HRG Publication #1542) [show all summaries]
• Comments Before the Food and Drug Association's Dermatologic and Ophthalmic Drugs Advisory Committee meeting on Isotretinoin (Accutane). (HRG Publication #1537) [show all summaries]
• Petition to the Food and Drug Administration to remove Lotronex from the market. (HRG Publication #1533) [show all summaries]
• Letter to Center for Drug Evaluation and Research urging the Food and Drug Administration (FDA) to reject the approval of Uprima (apomorphine0. (HRG Publication #1522) [show all summaries]
• Comments on the Department of Health and Human Services' Inspector General’s Study of Adverse Event Reporting for Dietary Supplements. (HRG Publication #1568) [show all summaries]
• Letter to the Food and Drug Administration/FDA asking for the immediate withdrawal of Propulsid (cisapride) from the market. (HRG Publication #1519) [show all summaries]
• Letter to the FDA requesting a criminal investigation of Warner Lambert/Parke Davis for what appears to be illegally delaying the submission of data known to the company before troglitazone was marketed. (HRG Publication #1515) [show all summaries]
• Petition to the Food and Drug Administration requesting that it immediately require labeling for the diabetes drugs troglitazone (Rezulin), rosiglitazone (Avandia) and pioglitazone (Actos)(HRG Publication #1514) [show all summaries]
• Letter to the Editor in the Journal of the American Medical Association in response to an article on the safety of Food and Drug Administration approved drugs which were withdrawn (HRG Publication #1502) [show all summaries]
• Letter to the Food and Drug Administration to immediately ban the antibiotic trovafloxacin (Trovan). (HRG Publication #1485) [show all summaries]
• Statement about a Food and Drug Adminstration article in the Journal of the American Medical Association regarding recently withdrawn drugs and the safety of newly approved drugs. (HRG Publication #1481) [show all summaries]
• Citizen's petition with the National Women's Health Network to the Food and Drug Administration to change the labeling on tamoxifen (Nolvadex). (HRG Publication #1479) [show all summaries]
• Statement before the Food and Drug Administration Endocrine and Metabolic Drugs Advisory Committee meeting advising them to withdraw troglitazone from the U.S. Market. (HRG Publication #1476) [show all summaries]
• Statement before the Food and Drug Administration's Cardiovascular and Renal Drugs advisory committee urging that they not approve dofetilide (Tikosyn) to prevent recurrent arrythmias. (HRG Publication #1472) [show all summaries]
• Letter to the Food and Drug Administration regarding an ad for troglitazone (Rezulin) in a Hispanic publication [show all summaries]
• Letter to the Food and Drug Administration concerning a study in the New England Journal of Medicine amplifying our concerns about the safety of cilostazol (HRG Publication #1468) [show all summaries]
• Statement before the Food and Drug Administration's Arthritis Drugs Advisory Committee on the nonsteroidal anti-inflammatory drug celexocib. (HRG Publication #1465) [show all summaries]
• Press Release Concerning FDA'S Approval of Tamoxifen to Reduce Incidence of Breast Cancer in Healthy Women Puts Women at Risk (HRG Publication #1464) [show all summaries]
• Letter to the FDA urging that they reject the application for approval of cilostazol (Pletal) as there are other remedies for a non-threatening condition (HRG Publication #1458) [show all summaries]
• Letter to the Medicines Control Agency, United Kingdom, urging them to require important warnings on labeling of sildenafil/Viagra. (HRG Publication #1454) [show all summaries]
• Letter to the Therapeutic Products Program in Canada urging them to require important warnings on the labeling of sildenafil/Viagra. (HRG Publication #1452) [show all summaries]
• Letter to the Food and Drug Administration urging them to immediately convene an advisory committee to review various serious problems related to the use of sildenafil/Viagra. (HRG Publication #1451) [show all summaries]
• Petition to the Food and Drug Administration to ban troglitazone/Rezulin due to its causing several cases of liver failure. (HRG Publication #1449) [show all summaries]
• Petition to the Food and Drug Administration to change the labeling and other sources of information on sildenafil/Viagra to reflect problems with the drug. (HRG Publication #1445) [show all summaries]
• Statement on the withdrawal of mibefradil/Posicor from the market. (HRG Publication #1441) [show all summaries]
• Response to the Institute of Medicine's Report on Halcion. (HRG Publication #1431) [show all summaries]
• HRG Letter to David Kessler Regarding Lancet Ad Discussing Demeaning Ways That Physicians Are Viewed (HRG Publication #1403) [show all summaries]
• HRG Comments on Direct-to-Consumer Prescription Drug Promotion dated 5/14/96. (HRG Publication #1400) [show all summaries]
• Petition to Require a Warning on All Fluoroquinolone Antibiotics (HRG Publication #1399) [show all summaries]
• Statement by Sidney M. Wolfe, MD, Concerning Petition to Repeal DOD/FDA Regulation Allowing Waiver for Informed Consent for Experimental Drugs (HRG Publication #1392) [show all summaries]
• Letter to FD Commissioner David Kessler Urging Him to Delay Approval of the Weight Control Drug Dexfenfluramine (HRG Publication #1389) [show all summaries]
• FDA Hearing on Calcium Channel Blockers [show all summaries]
• HRG Citizen's Petition to Require a Warning on All Calcium Channel Blocking Drugs (HRG Publication #1378) [show all summaries]
• Statement of Paul D. Stolley, MD, MPH that comments on the FDA Risk-Management Concept Papers (HRG Publication #1663) [show all summaries]

• Backsliding on Childhood Immunization [show all summaries]
  (June 2008)
• What Happened in U.S. Health Care in 2007? [show all summaries]
  (December 2007)
• Research as Public Relations: Antidepressants and Suicide in Youth [show all summaries]
  (October 2007)
• Diet Drug Poses Risks, Few Benefits [show all summaries]
  (February 2006)
• Sleight-of Hand: Merck Tried to Reformulate Vioxx in 2000 While Denying Risk [show all summaries]
  (August 2005)
• A Reminder About The Dangers of Aspirin and Reyes's Syndrome [show all summaries]
  (October 2003)
• Meridia — Weight Loss or Health Loss? [show all summaries]
  (October 2003)
• Drug Safety Withdrawals: Who is Responsible for Notifying Patients? [show all summaries]
  (December 2002)
• FDA Caves In to Industry, Fails to Adequately Address Tylenol Overdoses [show all summaries]
  (November 2002)
• Will a Vitamin a Day Keep the Doctor Away? [show all summaries]
  (October 2002)
• Outrage: Department of Health and Human Services Fails to Ban Ephedra or Issue Adequate Warnings [show all summaries]
  (July 2002)
• Outrage: Possible Corruption at the American Heart Association [show all summaries]
  (May 2002)
• Outrage: Do Not Use Ephedra [show all summaries]
  (October 2001)
• COX-2 Inhibitors Vioxx and Celebrex: Keep Staying Away--It Gets Worse [show all summaries]
  (March 2001)

• A Review of Exenatide (BYETTA) for Type-2 Diabetes [show all summaries]
  (November 2009)
• An Update on the HPV Vaccine GARDASIL [show all summaries]
  (November 2009)
• Insulin Glargine (LANTUS) and Cancer: Is There a Link? [show all summaries]
  (October 2009)
• Milnacipran (SAVELLA) Fails to Alleviate Fibromyalgia Pain, Has Safety Concerns [show all summaries]
  (September 2009)
• A Review of Shingles Vaccine ZOSTAVAX [show all summaries]
  (September 2009)
• New Study Further Links Alzheimer's Drugs to Serious Side Effects [show all summaries]
  (August 2009)
• Herbal Medicines for Menopausal Symptoms? Hang Onto Your Wallet and Your Health [show all summaries]
  (August 2009)
• FDA Requires Warnings about Serious Mental and other Side Effects With Certain Asthma Drugs [show all summaries]
  (August 2009)
• Another Chapter in the Long History of Exposing the Dangers of the Most Popular Drug in America [show all summaries]
  (July 2009)
• Muscle Damage from Interactions Between Statins and Other Commonly Prescribed Drugs [show all summaries]
  (July 2009)
• A Review of Lubiprostone (AMITIZA) for Irritable Bowel Syndrome with Constipation [show all summaries]
  (June 2009)
• Hypothyroidism: A Consumer’s Guide to Diagnosing and Treatment [show all summaries]
  (June 2009)
• The BOTOX Label Gets Ready for its Close-up [show all summaries]
  (June 2009)
• Alpha-Blockers for Prostate Enlargement: Some Important Drug Interactions [show all summaries]
  (June 2009)
• What Aspirin Dose Is Safest and Most Effective for Preventing Heart Disease? [show all summaries]
  (May 2009)
• WARNING: MRI Scans May Burn Patients Wearing Transdermal Drug Patches [show all summaries]
  (May 2009)
• LOVAZA: Limited Use Drug for Lowering Trigylcerides [show all summaries]
  (April 2009)
• Drug-induced Cognitive Impairment: Part 2: Delirium and Dementia [show all summaries]
  (April 2009)
• Drug-Induced Cognitive Impairment: Part One [show all summaries]
  (March 2009)
• Update: Oral Sodium Phosphate Used as Preparation for Colonoscopy Can Cause Kidney Damage [show all summaries]
  (March 2009)
• Long-term Use of Bisphosphonates for Osteoporosis [show all summaries]
  (January 2009)
• Public Citizen Urges Immediate Ban of Rosiglitazone (AVANDIA) [show all summaries]
  (December 2008)
• Osteoporosis Fracture Prevention: What You Need to Know about Drugs and other Measures - Part 2 [show all summaries]
  (December 2008)
• Update on Drugs that Can Cause High Blood Potassium [show all summaries]
  (December 2008)
• Muscle Injury From Use of Simvastatin (ZOCOR) with Amiodarone (CORDARONE) [show all summaries]
  (November 2008)
• New Evidence of Suicidal Thinking and Behavior In Patients Using Anti-Epileptic Drugs [show all summaries]
  (November 2008)
• Botox, Mark Spitz, Nadia Comaneci vs. Willie Nelson [show all summaries]
  (October 2008)
• FDA Must Warn Patients Taking Fluoroquinolone Antibiotics of Possible Tendon Ruptures [show all summaries]
  (October 2008)
• Worst Pills, Best Pills Review: Carisoprodol (SOMA, SOMA COMPOUND) [show all summaries]
  (October 2008)
• Massive Misprescribing of Inappropriate Drugs to Hospitalized Elderly Patients [show all summaries]
  (September 2008)
• The Growth Hormone Craze: Why it Should Be Used only Rarely [show all summaries]
  (August 2008)
• Update: Diabetes Drug JANUVIA (Sitagliptin) [show all summaries]
  (July 2008)
• Medications and the Perils of Too Little Sodium in the Blood [show all summaries]
  (July 2008)
• New Report Sheds Light on Serious Safety Problems with Anti-Smoking Drug Varenicline (CHANTIX) [show all summaries]
  (July 2008)
• Black Box Warning for ENBREL (etanercept) [show all summaries]
  (June 2008)
• Codeine: The Drug With Multiple Personalities [show all summaries]
  (June 2008)
• American Heart Association Recommends Screening for Heart Disease in Children Getting Drugs for ADHD [show all summaries]
  (June 2008)
• Public Citizen Petition Urges Removal of ORTHO-EVRA Patch From Market [show all summaries]
  (June 2008)
• A Review of Modafinil (PROVIGIL) For Narcolepsy [show all summaries]
  (May 2008)
• Drug-Induced Eye Toxicity: 62 Drugs That Can Cause Eye Disease [show all summaries]
  (April 2008)
• Advice for Patients: Denture Cleansers [show all summaries]
  (April 2008)
• Avoiding Overuse of Proton Pump Inhibitors (PPIs) [show all summaries]
  (March 2008)
• Get the Mercury Out! Is There a Link Between Childhood Vaccinations and Autism? [show all summaries]
  (March 2008)
• Ibuprofen Can Reduce Aspirin’s Protective Effect Against Heart Attacks and Strokes [show all summaries]
  (March 2008)
• Is Less More? New Study Challenges Conventional Thought on Desirable Cholesterol Levels, Links Very Low Cholesterol to Cancer [show all summaries]
  (February 2008)
• Update on Rosiglitazone (AVANDIA): More Strikes Against the Drug [show all summaries]
  (February 2008)
• Painkiller DARVOCET Now Phased Out of U.K. Market; Still Widely Prescribed in the U.S. [show all summaries]
  (January 2008)
• Taking TOPAMAX to Treat Alcoholism Could Have Serious Consequences [show all summaries]
  (December 2007)
• Drug Interactions: Warfarin (COUMADIN) [show all summaries]
  (December 2007)
• New European Warnings and Restrictions on Painkiller Piroxicam (FELDENE): FDA Fails to Issue New Warning [show all summaries]
  (November 2007)
• EU Warns About BOTOX Dangers: Why has the US failed to inform its residents? [show all summaries]
  (October 2007)
• Drug-Induced Diseases: Part 2 [show all summaries]
  (October 2007)
• A Review of Varenicline (CHANTIX) To Quit Smoking [show all summaries]
  (September 2007)
• Pharmacists Ordered to Distribute Medication Guides About Serious Heart, Psychiatric Problems Linked to Attention Deficit Drugs [show all summaries]
  (August 2007)
• FDA Issues New Warnings For Muscle Spasm Drug Tizanidine (ZANAFLEX) [show all summaries]
  (August 2007)
• Older Adults May Have Low Blood Sodium Levels When Using the Antidepressant Venlafaxine (EFFEXOR) [show all summaries]
  (August 2007)
• XYZAL: A Not-So-New Antihistamine [show all summaries]
  (August 2007)
• Q&A on the Human Papilloma Virus Vaccine Gardasil [show all summaries]
  (August 2007)
• New Findings: AVANDIA Poses Risks of Heart Attacks, Heart Failure [show all summaries]
  (July 2007)
• FDA: Women Taking AVANDIA, ACTOS at Increased Risk of Fractures [show all summaries]
  (July 2007)
• Human Growth Hormone Not Recommended as Antiaging Treatment [show all summaries]
  (July 2007)
• FDA: All Antidepressants Should Carry Warnings About Risks of Suicidal Thoughts in Young Adults [show all summaries]
  (July 2007)
• Desmopressin Removed From UK Market for Bedwetting But Still Approved in the US [show all summaries]
  (July 2007)
• Sitagliptin (JANUVIA) for Type-2 Diabetes [show all summaries]
  (June 2007)
• Drugmaker Removes Parkinson's Disease Medication from the Market; Drug Linked to Heart Valve Damage [show all summaries]
  (June 2007)
• The Diet Drug Orlistat (XENICAL) and Gallstones [show all summaries]
  (June 2007)
• Antibiotic Telithromycin (KETEK) Can Cause Liver Damage, Respiratory Failure and Death [show all summaries]
  (June 2007)
• FDA Pulls ZELNORM Off the Market for Safety Reasons [show all summaries]
  (June 2007)
• Methadone for Pain [show all summaries]
  (May 2007)
• FDA Requests New Safety Warnings for AMBIEN (Zolpidem), Other Sleeping Pills [show all summaries]
  (May 2007)
• Public Citizen Petitions FDA To Ban Oral Contraceptives Containing Desogestrel [show all summaries]
  (April 2007)
• Dangerous Abnormal Behavior In Children And Adolescents Treated With Flu Drug Oseltamivir (TAMIFLU) [show all summaries]
  (April 2007)
• Adverse Reactions to Cough and Cold Meds Sent 1500 Babies to the Emergency Room in 2004, 2005 [show all summaries]
  (March 2007)
• A Review of Ranolazine (RANEXA) For Chronic Chest Pain [show all summaries]
  (March 2007)
• Black Cohosh Does Not Relieve Symptoms of Menopause [show all summaries]
  (March 2007)
• Life-Threatening Adverse Effects and Deaths Reported in Patients Using Methadone (DOLOPHINE) for Pain Relief [show all summaries]
  (February 2007)
• FDA Warns Against the Use of Quinine to Prevent Nocturnal Leg Cramps, Orders Unapproved Quinine Drugs Off the Market [show all summaries]
  (February 2007)
• Adverse Drug Reactions Cause 1.4 Million Emergency Room Visits in 2004 and 2005 [show all summaries]
  (January 2007)
• Using Seizure and Depression Drug Lamotrigine (LAMICTAL) While Pregnant May Result in Birth Defects [show all summaries]
  (January 2007)
• Using Oral Terbinafine (LAMISIL) for Fungal Infections Poses Risks to Your Health [show all summaries]
  (January 2007)
• New Research: Cognitive Behavioral Therapy to Treat Insomnia is Superior to Sleeping Pills Such as Eszopiclone (LUNESTA) [show all summaries]
  (January 2007)
• The Case Against The Diabetes Drug Rosiglitazone (AVANDIA) [show all summaries]
  (December 2006)
• FDA Issues Stronger Warnings for ADHD Stimulants; Warnings Don’t Go Far Enough [show all summaries]
  (November 2006)
• Used as a Glaucoma Treatment, Beta-Blocker Eye Drops May Cause Serious Adverse Reactions in Some Patients [show all summaries]
  (November 2006)
• Public Citizen Urges FDA to Warn Consumers About Risk of Tendon Rupture Associated With Certain Antibiotics [show all summaries]
  (November 2006)
• Canadian Government Warns Against the Use of Dietary Supplement L-Arginine in Patients Who Have Had a Heart Attack [show all summaries]
  (November 2006)
• A Review of Ibandronate (BONIVA) For Osteoporosis [show all summaries]
  (October 2006)
• PUBLIC HEALTH ADVISORY: Continuing Antidepressants During Pregnancy May Help Mother, Harm Baby: A Medical Dilemma [show all summaries]
  (October 2006)
• New Study Links Signs of Possible Liver Damage to Lower Doses of Acetaminophen (TYLENOL), Supporting Previous Research [show all summaries]
  (September 2006)
• Death of Parts of the Jaw Bone With Osteoporosis Drugs Such As Alendronate (FOSAMAX) [show all summaries]
  (September 2006)
• A Review of the Antibiotic Telithromycin (KETEK) [show all summaries]
  (September 2006)
• FDA Public Health Advisory: Birth Defects with High Blood Pressure-Lowering Drugs Containing Angiotensin-Converting Enzyme (ACE) Inhibitors [show all summaries]
  (August 2006)
• Deaths In Children Using Promethazine (PHENERGAN) Increase; FDA Issues a Safety Alert and a Stronger Black Box Warning [show all summaries]
  (August 2006)
• Dietary Supplement Black Cohosh Linked to Liver Toxicity [show all summaries]
  (August 2006)
• Women Should Wait to Use Osteoporosis Drug Raloxifene (EVISTA) to Prevent Breast Cancer [show all summaries]
  (July 2006)
• Public Citizen Asks FDA to Immediately Remove Orlistat (XENICAL) from the Market [show all summaries]
  (June 2006)
• Health Research Group Petitions to Phase Out the Sale of the Painkiller Propoxyphene (DARVON, DARVOCET, and Generic Versions) [show all summaries]
  (June 2006)
• Nightmares Associated with Atorvastatin (LIPITOR) [show all summaries]
  (June 2006)
• Folic Acid and B Vitamins No Better Than Placebo in Heart Patients and May Cause Harm [show all summaries]
  (June 2006)
• Lung Inflammation (Pneumonitis) with the Arthritis Drug Leflunomide (ARAVA) [show all summaries]
  (June 2006)
• Adding Clopidogrel to Aspirin Offers No Benefit in Preventing Heart Attacks or Strokes [show all summaries]
  (May 2006)
• Celecoxib (CELEBREX) May Double the Risk for Heart Attacks Compared to Older Arthritis Drugs [show all summaries]
  (May 2006)
• FDA Relegates ADVAIR and SEREVENT to Last Choice Status for Asthma Treatment [show all summaries]
  (May 2006)
• Sustained High Blood Pressure with Antidepressant Venlafaxine Extended Release (EFFEXOR XR) [show all summaries]
  (May 2006)
• Some Diabetes Drugs May Cause Vision Problems: Rosiglitazone (AVANDIA) and Macular Edema [show all summaries]
  (April 2006)
• The Diagnostic Drug Technetium 99m Tc Fanolesomab (NEUTROSPEC) is Banned [show all summaries]
  (April 2006)
• FDA Issues Public Health Advisory About Liver Toxicity with the Antibiotic Telithromycin (KETEK) [show all summaries]
  (March 2006)
• Chronic Kidney Failure Linked to Certain Bowel Cleansing Products Used Prior to Colonoscopy [show all summaries]
  (March 2006)
• Increased Risk of Blood Clots with the Birth Control Patch Ethinyl Estradiol With Norelgestromin (ORTHO EVRA) [show all summaries]
  (March 2006)
• A Warning about AVINZA: Updated Black Box Warning on Extended-Release Morphine Capsules [show all summaries]
  (March 2006)
• Asthma Drugs Salmeterol (SEREVENT), Salmeterol with Fluticasone (ADVAIR), and Formoterol (FORADIL) [show all summaries]
  (March 2006)
• Increasing Number of Acute Liver Failure Cases Linked to Acetaminophen (TYLENOL) [show all summaries]
  (February 2006)
• Antipsychotic Drugs and Dementia in the Elderly [show all summaries]
  (February 2006)
• Fluoroquinolone Antibiotics Implicated in Life-Threatening Diarrhea [show all summaries]
  (February 2006)
• Serious Blood Sugar Reactions With the Fluoroquinolone Antibiotic Gatifloxacin (TEQUIN) [show all summaries]
  (February 2006)
• A Review of Sleeping Pill Ramelteon (ROZEREM) [show all summaries]
  (January 2006)
• Postmenopausal Hormone Replacement Therapy (HRT) and Urinary Incontinence [show all summaries]
  (January 2006)
• Erectile Dysfunction Drugs Can Cause Vision Loss [show all summaries]
  (January 2006)
• Safety Alert! Meningitis Vaccine and Serious Nervous System Adverse Reactions [show all summaries]
  (December 2005)
• Paxil and Birth Defects [show all summaries]
  (December 2005)
• Suicide Risk in Youth: Possible Strattera Connection [show all summaries]
  (December 2005)
• The Cholesterol-Lowering Statin Drugs and Memory Loss [show all summaries]
  (December 2005)
• Can a Drug Spur Pathological Gambling? Link Seen to Some Drugs Used to Treat Parkinson’s Disease [show all summaries]
  (November 2005)
• Vitamins: Useful or Harmful? [show all summaries]
  (November 2005)
• Thioridazine (MELLARIL): Sales Halted In Canada [show all summaries]
  (November 2005)
• Antibiotic Clarithromycin (BIAXIN) Can Have Deadly Interaction with Anti-Gout Drug Colchicine [show all summaries]
  (October 2005)
• Drug-Induced Car Crashes? Parkinson’s Disease Drugs and the Risk of Sudden Sleep [show all summaries]
  (October 2005)
• Extensive New Warnings for the Potent Pain Drug Fentanyl Transdermal System (DURAGESIC) [show all summaries]
  (October 2005)
• More Dangers From a Toxic Lice Treatment [show all summaries]
  (October 2005)
• Asthma Medicines That Can Cause Asthma Attacks: SEREVENT, ADVAIR and FORADIL [show all summaries]
  (September 2005)
• BIDIL, a Heart Drug Targeted at African Americans, Stirs Complex Controversy [show all summaries]
  (September 2005)
• Birth Control Patch ORTHO EVRA Linked to Dangerous Blood Clots [show all summaries]
  (September 2005)
• The Dark Side of Viagra: Erectile Dysfunction Drugs And Vision Problems [show all summaries]
  (August 2005)
• Zoledronic Acid (ZOMETA) And Pamidronate (AREDIA) Linked to Jaw Bone Damage: Popular Osteoporosis Drugs Also Evaluated [show all summaries]
  (August 2005)
• Aspirin To Prevent Cardiovascular Disease In Women — Is The Picture Any Clearer? [show all summaries]
  (August 2005)
• Rosuvastatin (CRESTOR) - The Most Dangerous Cholesterol-Lowering Statin Drug [show all summaries]
  (July 2005)
• FDA Public Health Advisory: Unapproved Use of Atypical Antipsychotics Increases Risk of Death [show all summaries]
  (July 2005)
• A Review of Eszopiclone (LUNESTA): A Not-So-New Sleeping Pill [show all summaries]
  (July 2005)
• Serious Skin Reactions with the Seizure Drug Oxcarbazepine (TRILEPTAL) [show all summaries]
  (June 2005)
• FDA Public Health Advisory - Arthritis Drug Valdecoxib (BEXTRA) Removed From Market; Major New Warnings for Other NSAIDs [show all summaries]
  (June 2005)
• A Review of Solifenacin (VESICARE) and Darifenacin (ENABLEX) for Overactive Bladder [show all summaries]
  (May 2005)
• Vitamin E For Cancer And Heart Disease — Enough Is Enough [show all summaries]
  (May 2005)
• Public Health Advisory Potential Risk Of Cancer With Eczema Treatments Pimecrolimus (ELIDEL) And Tacrolimus (PROTOPIC) [show all summaries]
  (May 2005)
• REMINDER —The Heartburn Drug Metoclopramide (REGLAN) Can Cause Drug-Induced Movement Disorders [show all summaries]
  (May 2005)
• FDA-Approved Patient Information For The Heart Drug Amiodarone (CORDARONE) — A Last Choice Drug For Life-Threatening Heart Rhythm Disturbances [show all summaries]
  (April 2005)
• British To Ban The Combination Painkiller Containing Propoxyphene With Acetaminophen [show all summaries]
  (April 2005)
• NEW BLACK BOX WARNING! Respiratory Depression And Death With The Antinausea Drug Promethazine (PHENERGAN) [show all summaries]
  (April 2005)
• PUBLIC HEALTH ADVISORY Seizures In Patients Without Seizure Disorder Being Treated With Tiagabine (GABITRIL) [show all summaries]
  (April 2005)
• Deaths Attributed To The Alzheimer’s Disease Drug Galantamine (REMINYL) [show all summaries]
  (March 2005)
• Serious GI Toxicity With The Heart Drug Clopidogrel (PLAVIX) [show all summaries]
  (March 2005)
• Problems With COX-2 Inhibitors Vault Meloxicam (MOBIC) To Blockbuster Status [show all summaries]
  (March 2005)
• Cutting Your Drug Bill While Reducing Your Risk Of Avoidable Adverse Drug Reactions: Six Examples [show all summaries]
  (February 2005)
• Liver Toxicity With New ADHD Drug Atomoxetine (STRATTERA) [show all summaries]
  (February 2005)
• Black Box Warning For The Injectable Contraceptive Medroxyprogesterone Acetate (DEPO-PROVERA) [show all summaries]
  (February 2005)
• Duloxetine (CYMBALTA) for Major Depressive Disorder - Nothing Special and Possible Liver Toxicity [show all summaries]
  (January 2005)
• Revisiting Clopidogrel (PLAVIX) Plain Aspirin Still Preferred in Preventing Stroke, Heart Attack and Blood Clots [show all summaries]
  (January 2005)
• A Review of Ezetimibe (ZETIA) and Ezetimibe with Simvastatin (VYTORIN) For Cholesterol Lowering [show all summaries]
  (December 2004)
• Reporting Rate For Kidney Damage Is 75 Times Higher With Crestor (Rosuvastatin) [show all summaries]
  (December 2004)
• Black Box Warning To Be Required On All Antidepressants Concerning Suicide Risk In Children And Adolescents [show all summaries]
  (December 2004)
• Drug Induced Peripheral Neuropathy From The Fluroquinolone Antibiotics [show all summaries]
  (December 2004)
• Manufacturer Finally Admits Heart Risks With The Arthritis Drug Valdecoxib (BEXTRA) [show all summaries]
  (December 2004)
• Blockbuster Arthritis Drug Rofecoxib (VIOXX) Withdrawn From Market [show all summaries]
  (November 2004)
• The Widely Used Antibiotic Erythromycin And Fatal Heart Rhythm Disturbances [show all summaries]
  (November 2004)
• A Review of Trospium (SANCTURA) for Overactive Bladder [show all summaries]
  (November 2004)
• Tiotropium (SPIRIVA) for Chronic Obstructive Pulmonary Disease (COPD). Is it an Important Advance? [show all summaries]
  (October 2004)
• A Review of Irritable Bowel Syndrome Drug Tegaserod (ZELNORM) Now Approved for Chronic Constipation [show all summaries]
  (October 2004)
• Drugs That Can Cause Headache From Their Overuse [show all summaries]
  (October 2004)
• Canadians Warned of Potential Adverse Effects of Maternal Use of Antidepressants on Newborns. American Mothers Still in the Dark [show all summaries]
  (October 2004)
• Lawsuit Reveals Serious Safety Problems with the Nonsteroidal Anti-inflammatory Drug Valdecoxib (BEXTRA) [show all summaries]
  (September 2004)
• Suicide Risk Added To The Professional Product Labeling For Eight Antidepressants [show all summaries]
  (August 2004)
• Food and Drug Administration Warns Against The Use Of The Unapproved Drug Domperidone To Increase Milk Production [show all summaries]
  (August 2004)
• A Review of New Antibiotic Telithromycin (KETEK) [show all summaries]
  (June 2004)
• Dangerous Antidepressant Nefazodone (SERZONE) Now Withdrawn From the Market in Europe, Canada, Australia and New Zealand [show all summaries]
  (June 2004)
• CBS Evening News on Serzone: New Concerns Over Anti-Depressant [show all summaries]
  (June 2004)
• Dangerous Drug for Irritable Bowel Syndrome: Constipation-Predominant Tegaserod (ZELNORM) [show all summaries]
  (June 2004)
• Aspirin and Heart Attacks: Secondary Prevention, Yes; Primary Prevention, No [show all summaries]
  (May 2004)
• The Newer Atypical Antipsychotic Drug Olanzapine (ZYPREXA) Shows No Advantage Over Haloperidol (HALDOL) [show all summaries]
  (May 2004)
• The Antidepressant Fluoxetine (Prozac) and Suicidal Ideation — Déjà vu 1991 [show all summaries]
  (May 2004)
• The Inappropriate Prescribing of the Acne Drug Isotretinoin (ACCUTANE) Continues [show all summaries]
  (April 2004)
• Updates: Rosuvastatin (CRESTOR) and Nefazodone (SERZONE) [show all summaries]
  (April 2004)
• Further Updates on the Cholesterol-Lowering Statin Drug Rosuvastatin (CRESTOR) [show all summaries]
  (March 2004)
• Arthritis Drug Leflunomide (ARAVA) Linked to Japanese Deaths from Lung Disease [show all summaries]
  (March 2004)
• FDA Updates Hormone Therapy (HRT) Information for Post-Menopausal Women: HRT Causes Dementia [show all summaries]
  (March 2004)
• The FDA Finally Bans Ephedra [show all summaries]
  (February 2004)
• A Review of Seizure Medication Topiramate (TOPAMAX) for Weight Reduction [show all summaries]
  (February 2004)
• Pergolid Mesylate (PERMAX): Warning About Falling Asleep and Auto Accidents [show all summaries]
  (February 2004)
• A Review of Two More Drugs For Erectile Dysfunction: Vardenafil (LEVITRA) And Tadalifil (CIALIS) [show all summaries]
  (January 2004)
• New Warnings About Fatal Liver Toxicity And Infections For The Arthritis Drug Leflunomide (ARAVA) [show all summaries]
  (January 2004)
• DO NOT USE UNTIL 2011 Eplerenone (INSPRA) For High Blood Pressure [show all summaries]
  (December 2003)
• FDA Issues Public Health Advisory On Antidepressants And Suicide Risk In Children [show all summaries]
  (December 2003)
• DO NOT USE! Dangerous Antidepressant Nefazodone (SERZONE) Withdrawn From The Market In Canada HRG Files Second Petition to Ban Nefazadone [show all summaries]
  (December 2003)
• Another Drug Safety Withdrawal - The Opioid Dependence Drug Levomethadyl (ORLAAM) [show all summaries]
  (November 2003)
• DO NOT USE! Strong New Safety Warning Added For The Asthma Inhaler Salmeterol (SEREVENT) [show all summaries]
  (November 2003)
• A Reminder About The Dangers Of Aspirin And Reye’s Syndrome [show all summaries]
  (November 2003)
• Do Not Use! Rosuvastatin (Crestor) - A New But More Dangerous Cholesterol Lowering 'Statin' Drug [show all summaries]
  (October 2003)
• Important New Warnings! The Use Of The Antidepressant Venlafaxine (EFFEXOR, EFFEXOR XR) In Children And Adolescents [show all summaries]
  (October 2003)
• Severe Neuropsychiatric Adverse Effects Associated With The Antimalarial Drug Mefloquine (LARIAM) [show all summaries]
  (September 2003)
• Dangerous, Inappropriate Prescribing Of Diabetes Drugs Metformin (GLUCOPHAGE), Rosiglitazone (AVANDIA), And Pioglitazone (ACTOS) To Patients With Heart Failure [show all summaries]
  (September 2003)
• The Serotonin Syndrome: A Potentially Life-Threatening Adverse Drug Reaction — Fluoxetine (PROZAC), Escitalopram (LEXAPRO), Sibutramine (MERIDIA) And Other Drugs [show all summaries]
  (September 2003)
• Drug-Induced Taste Disorders [show all summaries]
  (September 2003)
• New Warnings For The Seizure Drug Topiramate (TOPAMAX) [show all summaries]
  (September 2003)
• Do Not Use Finasteride (PROSCAR, PROPECIA) For Preventing Prostate Cancer [show all summaries]
  (August 2003)
• FDA Issues Safety Advisory Recommending Against Use Of Selective Serotonin Re-Uptake Inhibitor (SSRI) Antidepressant Paroxetine (PAXIL) In Children [show all summaries]
  (August 2003)
• Seizure Medication Lamotrigine (LAMICTAL) Approved For Use In Bipolar Disorder [show all summaries]
  (August 2003)
• Oxybutynin Patches (OXYTROL): A Grossly Overpriced Product For Overactive Bladder [show all summaries]
  (July 2003)
• Heart Failure After Treatment With Etanercept (ENBREL) and Infliximab (REMICADE) - Drugs Used For Rheumatoid Arthritis and Crohn's Disease [show all summaries]
  (July 2003)
• Inappropriate Prescribing Of Fluoroquinolone Antibiotics, Ciprofloxacin (CIPRO), Gatifloxacin (TEQUIN), And Others [show all summaries]
  (July 2003)
• Do Not Use Until December 2009 The New Antipsychotic Drug Aripiprazole (ABILIFY) [show all summaries]
  (June 2003)
• NEW WARNING! Risk Of Stroke When The Antipsychotic Risperidone (RISPERDAL) Is Prescribed For Dementia [show all summaries]
  (June 2003)
• Do Not Use! Reports of Blood Clots With the Use of the Oral Contraceptive Drospirenone With Ethinyl Estradiol (YASMIN) [show all summaries]
  (May 2003)
• The Tetracycline Antibiotic Minocycline (MINOCIN) and Benign Intracranial Hypertension [show all summaries]
  (May 2003)
• Stronger Warnings for the Fluoroquinolone Antibiotic Gatifloxacin (TEQUIN) [show all summaries]
  (May 2003)
• DO NOT USE! Teriparatide (FORTEO) — A New Drug For Osteoporosis [show all summaries]
  (April 2003)
• DO NOT USE! Nitrofurantoin (FURADANTIN, MACRODANTIN, MACROBID) — Adverse Effects On the Lungs [show all summaries]
  (April 2003)
• Resisting Antibiotic-Resistant Bacteria [show all summaries]
  (April 2003)
• New Warning! Heart Valve Damage With the Parkinson’s Disease Drug Pergolide (PERMAX) [show all summaries]
  (April 2003)
• Important Safety Alert! Antidepressant Nefazodone (SERZONE) Withdrawn From the Market In All European Countries [show all summaries]
  (March 2003)
• Important Safety Alert! DO NOT USE — Asthma Inhaler Salmeterol (SEREVENT) [show all summaries]
  (March 2003)
• Overdoses and Lung Toxicity With Methotrexate When Used for Rheumatoid Arthritis and Other Diseases [show all summaries]
  (March 2003)
• Foggy Thinking as Inhaled Flu Vaccine Nears FDA Approval [show all summaries]
  (February 2003)
• Breathing Problems In Older Adults Using Beta-Blocking Eye Drops For Glaucoma [show all summaries]
  (February 2003)
• Do Not Use! The Water Pill (diuretic) Indapamide (LOZOL) for High Blood Pressure [show all summaries]
  (January 2003)
• Do Not Use! New Safety Warning Added to the Arthritis Drug Valdecoxib (BEXTRA) [show all summaries]
  (January 2003)
• Arthritis Drug Rofecoxib (VIOXX) Linked to Increased Risk of Coronary Heart Disease [show all summaries]
  (December 2002)
• Drug Induced Psychiatric Symptoms (Part 2) [show all summaries]
  (November 2002)
• New Safety Warnings! Dihydroergotamine (DHE 45 INJECTION, MIGRANAL NASAL SPRAY) for Migraine Headache [show all summaries]
  (November 2002)
• FDA Caves In to Industry, Fails to Adequately Address Acetaminophen (TYLENOL) Overdoses [show all summaries]
  (November 2002)
• Drug Induced Psychiatric Symptoms [show all summaries]
  (October 2002)
• Canada Bans the Dangerous Herbal Supplement Kava-Kava [show all summaries]
  (October 2002)
• Long Term Hormone Replacement Therapy (HRT): The Demise of a Standard of Practice [show all summaries]
  (September 2002)
• New Safety Labeling Change: Chlorpropamide (DIABINESE) for Type-2 Diabetes [show all summaries]
  (September 2002)
• New Safety Labeling Changes for Anticoagulant Warfarin (COUMADIN) [show all summaries]
  (September 2002)
• Comparative Gastrointestinal (GI) Toxicity of Six Nonsteroidal Anti-inflammatory Drugs (NSAIDs) [show all summaries]
  (August 2002)
• Do Not Use! Dexmethylphenidate (FOCALIN) - a Methylphenidate (RITALIN) Copy [show all summaries]
  (August 2002)
• Do Not Use! Germany Bans the Dietary Supplement Kava-Kava [show all summaries]
  (August 2002)
• Public Citizen Health Research Group Publishes Companion to Worst Pills, Best Pills 1999 Edition [show all summaries]
  (July 2002)
• Drug Induced Elevation of Blood Sugar with the Antipsychotic Drugs Clozapine (CLOZARIL) and Olanzapine (ZYPREXA) [show all summaries]
  (July 2002)
• Do Not Use! The Fluoroquinolone Antibiotic Gatifloxacin (TEQUIN) [show all summaries]
  (July 2002)
• Health Research Group Petitions to Ban the Arthitis Drug Leflunomide (ARAVA) [show all summaries]
  (June 2002)
• Important New Cardiovascular Safety Warning for Rofecoxib (VIOXX) [show all summaries]
  (June 2002)
• Public Citizen's Health Research Group's Petition to Ban Diet Drug Sibutramine (MERIDIA) [show all summaries]
  (May 2002)
• U.S. Consumers Finally Get Warned About Liver Toxicity with the Dietary Supplement Kava-Kava [show all summaries]
  (May 2002)
• FDA Strengthens Warnings for Droperidol (INAPSINE) after the Drug Was Banned in Britain [show all summaries]
  (April 2002)
• New Safety Labeling Change: Black Box Warning about Heart Inflammation (Myocarditis) with Clozapine (CLOZARIL) [show all summaries]
  (April 2002)
• Do Not Use! The Pain Drug Tramadol (ULTRAM/ULTRACET) and Serotonin Syndrome [show all summaries]
  (March 2002)
• Do Not Use! Life-threatening Liver Toxicity with the Antidepressant Nefazadone (SERZONE) [show all summaries]
  (February 2002)
• New Adverse Drug Reaction: Elevated Blood Sugar from New Antipsychotic Drugs in Adolescents [show all summaries]
  (February 2002)
• Canadians Begin Recall of Dangerous Drug Supplement Ephedra [show all summaries]
  (February 2002)
• Do Not Use! The Flu Drug Zanamivir (RELENZA) Revisited [show all summaries]
  (January 2002)
• Do Not Use! Germans May Ban the Dietary Supplement Drug Kava-Kava [show all summaries]
  (January 2002)
• Do Not Use! LIPOKINETIX - A Liver Toxic Dietary Supplement Weight Loss Drug [show all summaries]
  (January 2002)
• Do Not Use. Europeans Strengthen Liver Toxicity Warnings on the Arthritis Drug Leflunomide (ARAVA) [show all summaries]
  (December 2001)
• Two New Warnings! Tuberculosis and Heart Failure with Infliximab (REMICADE) [show all summaries]
  (December 2001)
• FDA’s ‘New’ Program to Prevent Birth Defects Caused By Acne Drug Isotretinoin (ACCUTANE) Is Powerless [show all summaries]
  (December 2001)
• Drugs for Possible Exposure to Anthrax: What Makes Sense? [show all summaries]
  (November 2001)
• Serious Vision Disorder With Topiramate (TOPAMAX) [show all summaries]
  (November 2001)
• New Safety Warning For the Alzheimer’s Disease Drug Rivastigmine (EXELON) [show all summaries]
  (March 2001)
• Irritable Bowel Syndrome (IBS) Drug Alosetron (LOTRONEX) Withdrawn From the Market [show all summaries]
  (January 2001)

• benzphetamine (DIDREX); diethylpropion (TENUATE, TEPANIL); phendimetrazine (PLEGINE); phentermine (ADIPEX-P, FASTIN)
• orlistat (ALLI, XENICAL)
• sibutramine (MERIDIA)
• levonorgestrel and ethinyl estradiol [oral contraceptive] (ALESSE 28, AVIANE, NORDETTE, SEASONALE, TRIPHASIL, TRIVORA-28); norethindrone and ethinyl estradiol (COMBI PATCH, LOESTRIN FE 1/20, NEOCON 1/35, ORTHO-NOVUM 7/7/7, OVCON 35); norgestimate and ethinyl estradiol (ORTHO-CYCLEN, ORTHOTRI-CYCLEN, TRINESSA); norgestrel and ethinyl estradiol (LO/OVRAL 28, LOW-OGESTREL)
• desogestrel and ethinyl estradiol (DESOGEN, MIRCETTE, ORTHO-CEPT)
• drospirenone and ethinyl estradiol (YASMIN)
• dextroamphetamine (DEXEDRINE); various amphetamines (ADDERALL, ADDERALL XR)
• atomoxetine (STRATTERA)
• dexmethylphenidate (FOCALIN, FOCALIN XR)
• methylphenidate [extended release] (CONCERTA, DAYTRANA [TRANSDERMAL], METADATE CD, METADATE ER, METHYLIN ER, RITALIN LA); methylphenidate [immediate release] (METHYLIN, RITALIN); methylphenidate [sustained release] (RITALIN-SR)
• pemoline (CYLERT)
• conjugated estrogens (PREMARIN); estradiol [patch] (CLIMARA); synthetic conjugated estrogens (CENESTIN)
• progesterone (PROMETRIUM)
• tamoxifen (NOLVADEX)
• conjugated estrogens with medroxyprogesterone (PREMPHASE, PREMPRO); ethinyl estradiol with norethindrone (FEMHRT)
• esterified estrogens with methyltestosterone (ESTRATEST, ESTRATEST HS)
• acetohexamide (DYMELOR); chlorpropamide (DIABINESE)
• glimepiride (AMARYL); glipizide (GLUCOTROL); glyburide (DIABETA, GLYNASE, MICRONASE); tolazamide (TOLINASE); tolbutamide (ORINASE)
• glargine insulin (LANTUS); human insulin (HUMULIN, ILETIN, INSULATARD, MIXTARD, NOVOLIN, VELOSULIN); lispro insulin (HUMALOG)
• pioglitazone (ACTOS); rosiglitazone (AVANDIA)
• metformin (GLUCOPHAGE)
• nateglinide (STARLIX); repaglinide (PRANDIN)
• alfuzosin (UROXATRAL); doxazosin [prostate] (CARDURA [PROSTATE]); tamsulosin (FLOMAX); terazosin [prostate] (HYTRIN [PROSTATE])
• finasteride (PROSCAR)
• almotriptan (AXERT); eletriptan (RELPAX); frovatriptan (FROVA); naratriptan (AMERGE); rizatriptan (MAXALT, MAXALT MLT); sumatriptan (IMITREX); zolmitriptan (ZOMIG, ZOMIG ZMT)
• citalopram (CELEXA); fluoxetine (PROZAC, SERAFEM); fluvoxamine (LUVOX); paroxetine (PAXIL, PEXEVA); sertraline (ZOLOFT)
• amoxapine (ASENDIN); doxepin (SINEQUAN); imipramine (TOFRANIL, TOFRANIL PM)
• carisoprodol (SOMA); carisoprodol with aspirin (SOMA COMPOUND); carisoprodol, aspirin and codeine (SOMA COMPOUND WITH CODEINE)
• chlorzoxazone (PARAFON FORTE DSC)
• cyclobenzaprine (FLEXERIL)
• methocarbamol (ROBAXIN)
• orphenadrine (NORFLEX); orphenadrine, aspirin and caffeine (NORGESIC FORTE)
• bupropion [smoking] (ZYBAN)
• desipramine (NORPRAMIN); nortriptyline (AVENTYL, PAMELOR)
• amitriptyline (ELAVIL)
• amitriptyline and chlordiazepoxide (LIMBITROL)
• amitriptyline and perphenazine (TRIAVIL)
• bupropion [mind] (WELLBUTRIN)
• alendronate (FOSAMAX); risedronate (ACTONEL)
• raloxifene (EVISTA)
• calcitonin [calcitonin-salmon] (MIACALCIN)
• teriparatide (FORTEO)
• thioridazine (MELLARIL)
• thiothixene (NAVANE)
• maprotiline (LUDIOMIL)
• chlorpromazine (THORAZINE); fluphenazine (PROLIXIN); trifluoperazine (STELAZINE)
• lithium (ESKALITH, LITHOBID, LITHONATE)
• mirtazapine (REMERON)
• nefazodone (SERZONE)
• trazodone (DESYREL)
• venlafaxine (EFFEXOR, EFFEXOR XR)
• clozapine (CLOZARIL, FAZACLO ODT)
• olanzapine (ZYPREXA)
• alprazolam (XANAX); chlordiazepoxide (LIBRIUM); clorazepate (TRANXENE); diazepam (VALIUM); estazolam (PROSOM); flurazepam (DALMANE); halazepam (PAXIPAM); lorazepam (ATIVAN); prazepam (CENTRAX); quazepam (DORAL); temazepam (RESTORIL); triazolam (HALCION)
• quetiapine (SEROQUEL)
• risperidone (RISPERDAL)
• ziprasidone (GEODON, ZELDOX)
• oxazepam (SERAX)
• zolpidem (AMBIEN)
• haloperidol (HALDOL)
• mesoridazine (SERENTIL (DISCONTINUED))
• buspirone (BUSPAR)
• meprobamate (EQUANIL, MILTOWN)
• aripiprazole (ABILIFY)
• acetazolamide (DIAMOX); methazolamide (NEPTAZANE)
• betaxolol - eye (BETOPTIC, BETOPTIC S); levobunolol (BETAGAN); timolol [eye drops] (TIMOPTIC)
• brimonidine (ALPHAGAN)
• dorzolamide (TRUSOPT); dorzolamide and timolol (COSOPT)
• latanoprost (XALATAN)
• pilocarpine (ADSORBOCARPINE, ISOPTO CARPINE)
• sulfacetamide (SULAMYD)
• sulfacetamide and prednisolone (BLEPHAMIDE, VASOCIDIN)
• moxifloxacin [eye drops] (VIGAMOX); ofloxacin [eye] (OCUFLOX)
• fluorometholone (FML)
• neomycin and dexamethasone (NEODECADRON); neomycin p, polymyxin b, and dexamethasone (MAXITROL)
• olopatadine (PATANOL)
• oxybutynin (DITROPAN, DITROPAN XL, OXYTROL TRANSDERMAL SYSTEM); tolterodine (DETROL, DETROL LA)
• phenazopyridine (PYRIDIUM)
• dexamethasone (DECADRON, HEXADROL, MYMETHASONE); hydrocortisone [oral] (CORTEF, HYDROCORTONE); methylprednisolone (MEDROL); prednisolone (PRELONE); prednisone (DELTASONE)
• ibuprofen (ADVIL, MEDIPREN, MOTRIN, NUPRIN)
• diclofenac (VOLTAREN); etodolac (LODINE); fenoprofen (NALFON); flurbiprofen (ANSAID, OCUFEN); ketoprofen (ORUDIS); meclofenamate (MECLOMEN); mefenamic acid (PONSTEL); nabumetone (RELAFEN); naproxen (ALEVE, ANAPROX, NAPROSYN); oxaprozin (DAYPRO); sulindac (CLINORIL); tolmetin (TOLECTIN)
• indomethacin (INDOCIN)
• ketorolac (TORADOL)
• piroxicam (FELDENE)
• celecoxib (CELEBREX); meloxicam (MOBIC); rofecoxib (VIOXX); valdecoxib (BEXTRA)
• aspirin (EASPRIN, ECOTRIN, EMPIRIN, GENUINE BAYER ASPIRIN)
• buffered aspirin (ASCRIPTIN, BUFFERIN); diflunisal (DOLOBID); salsalate (DISALCID)
• acetaminophen (TYLENOL)
• acetaminophen and codeine (APAP, TYLENOL WITH CODEINE); acetaminophen and hydrocodone (BANCAP-HC, LORTAB, VICODIN); acetaminophen and oxycodone (PERCOCET, ROXICET, TYLOX); aspirin and oxycodone (PERCODAN); codeine; hydrocodone and ibuprofen (VICOPROFEN); hydromorphone (DILAUDID); meperidine (DEMEROL); morphine (AVINZA, KADIAN, MS CONTIN); oxycodone (OXYCONTIN)
• fentanyl [patch] (DURAGESIC)
• methadone (DOLOPHINE, METHADOSE)
• donepezil (ARICEPT); tacrine (COGNEX)
• galantamine (RAZADYNE, RAZADYNE ER, REMINYL); rivastigmine (EXELON)
• memantine (NAMENDA)
• butorphanol (STADOL)
• pentazocine (TALWIN); pentazocine and naloxone (TALWIN-NX)
• propoxyphene (DARVON, DARVON-N); propoxyphene and acetaminophen (DARVOCET-N, PROPOXACET-N, WYGESIC); propoxyphene, aspirin and caffeine (DARVON COMPOUND, DARVON COMPOUND-65)
• tramadol (ULTRAM); tramadol and acetaminophen (ULTRACET)
• butalbital, acetaminophen and caffeine (ESGIC PLUS, FIORICET); butalbital, caffeine and aspirin (FIORINAL); butalbital, caffeine, aspirin and codeine (FIORINAL WITH CODEINE)
• adalimumab (HUMIRA); anakinra (KINERET); etanercept (ENBREL); infliximab (REMICADE)
• allopurinol (ZYLOPRIM)
• azathioprine (IMURAN)
• colchicine
• benztropine (COGENTIN); trihexyphenidyl (ARTANE)
• bromocriptine (PARLODEL)
• entacapone (COMTAN); entacapone with levodopa and carbidopa (STALEVO)
• tolcapone (TASMAR)
• clonazepam (KLONOPIN)
• divalproex (DEPAKENE/DEPAKOTE); valproic acid (DEPAKENE)
• phenobarbital (LUMINAL, SOLFOTON)
• phenytoin (DILANTIN)
• tizanidine (ZANAFLEX)
• hydroxychloroquine (PLAQUENIL)
• leflunomide (ARAVA)
• methotrexate (TREXALL)
• probenecid (PROBALAN)
• vitamin A [retinol] (AQUASOL A)
• niacin [vitamin B3] (NICOLAR)
• vitamin D (CALCIFEROL)
• vitamin E [alpha tocopherol]
• chlorothiazide (DIURIL); chlorthalidone (HYGROTON); hydrochlorothiazide (ESIDRIX, HYDRODIURIL, MICROZIDE); methyclothiazide (ENDURON); metolazone (DIULO, ZAROXOLYN); polythiazide (RENESE)
• indapamide (LOZOL)
• bumetanide (BUMEX); furosemide (LASIX)
• amiloride and hydrochlorothiazide (MODURETIC)
• eplerenone (INSPRA)
• spironolactone (ALDACTONE)
• spironolactone and hydrochlorothiazide (ALDACTAZIDE)
• triamterene (DYRENIUM)
• triamterene and hydrochlorothiazide (DYAZIDE, MAXZIDE)
• candesartan (ATACAND); candesartan and hydrochlorothiazide (ATACAND HCT); eprosartan (TEVETEN); irbesartan (AVAPRO); irbesartan and hydrochlorothiazide (AVALIDE); losartan (COZAAR); losartan and hydrochlorothiazide (HYZAAR); olmesartan (BENICAR); olmesartan and hydrochlorothiazide (BENICAR HCT); telmisartan (MICARDIS); telmisartan and hydrochlorothiazide (MICARDIS HCT); valsartan (DIOVAN); valsartan and hydrochlorothiazide (DIOVAN HCT)
• acebutolol (SECTRAL); atenolol (TENORMIN); atenolol and chlorthalidone (TENORETIC); betaxolol - heart (KERLONE); bisoprolol (ZEBETA); bisoprolol and hydrochlorothiazide (ZIAC); carvedilol (COREG); labetalol (NORMODYNE, TRANDATE); metoprolol (LOPRESSOR, TOPROL XL); metoprolol and hydrochlorothiazide (LOPRESSOR HCT); nadolol (CORGARD); penbutolol (LEVATOL); pindolol (VISKEN); propranolol (INDERAL, INDERAL LA); propranolol and hydrochlorothiazide (INDERIDE LA); timolol [heart] (BLOCADREN); timolol and hydrochlorothiazide (TIMOLIDE)
• benazepril (ETHEX, LOTENSIN); benazepril and hydrochlorothiazide (LOTENSIN HCT); captopril (CAPOTEN); captopril and hydrochlorothiazide (CAPOZIDE); enalapril (VASOTEC); enalapril and hydrochlorothiazide (VASERETIC); fosinopril (MONOPRIL); lisinopril (PRINIVIL, ZESTRIL); lisinopril and hydrochlorothiazide (PRINZIDE, ZESTORETIC); moexipril (UNIVASC); perindopril (ACEON); quinapril (ACCUPRIL); ramipril (ALTACE); trandolapril (MAVIK)
• amlodipine (NORVASC); diltiazem (CARDIZEM, CARDIZEM CD, DILACOR XR, TIAZAC); felodipine (PLENDIL); isradipine (DYNACIRC, DYNACIRC CR); nicardipine (CARDENE, CARDENE SR); nifedipine (ADALAT CC, PROCARDIA XL); nisoldipine (SULAR); verapamil (CALAN, CALAN SR, COVERA-HS, ISOPTIN, ISOPTIN SR, VERELAN)
• hydralazine (APRESOLINE); hydralazine and hydrochlorothiazide (APRESOLINE ESIDREX)
• clonidine (CATAPRES); clonidine and chlorthalidone (COMBIPRES); clonidine transdermal therapeutic system (CATAPRES-TTS)
• gemfibrozil (LOPID)
• fenofibrate (TRICOR)
• azelastine (ASTELIN)
• fluvastatin (LESCOL, LESCOL XL)
• atorvastatin (LIPITOR); lovastatin (MEVACOR); lovastatin extended release (ALTOCOR); pravastatin (PRAVACHOL); simvastatin (ZOCOR)
• rosuvastatin (CRESTOR)
• niacin extended [intermediate] release (NIASPAN)
• ezetimibe (ZETIA)
• cetirizine (ZYRTEC); hydroxyzine (ATARAX, HY-PAM, VISTARIL)
• chlorpheniramine (ALERMINE, CHLOR-TRIMETON); chlorpheniramine injection; diphenhydramine (BENADRYL, DYTAN SUSPENSION, DYTAN-D SUSPENSION, SOMINEX FORMULA); diphenhydramine injection
• cholestyramine (LOCHOLEST, QUESTRAN, QUESTRAN LIGHT)
• cyproheptadine (PERIACTIN)
• desloratadine (CLARINEX)
• fexofenadine (ALLEGRA); loratadine (CLARITIN)
• disopyramide (NORPACE)
• pseudoephedrine (SUDAFED)
• dextromethorphan (DELSYM)
• procainamide (PROCANBID)
• mexiletine (MEXITIL)
• amiodarone (CORDARONE, PACERONE)
• quinidine (DURAQUIN, QUINAGLUTE DURA-TABS, QUINIDEX)
• digoxin (DIGITEK, LANOXICAPS, LANOXIN)
• pentoxifylline (TRENTAL)
• warfarin (COUMADIN)
• clopidogrel (PLAVIX)
• ticlopidine (TICLID)
• extended release potassium supplements (K-DUR, K-TABS); potassium supplements (K-LOR, KAOCHLOR, KAON-CL, KATO, KAY/CIEL, KLOTRIX, MICRO-K, SLOW-K)
• benzonatate (TESSALON)
• hydrocodone and homatropine (HYCODAN)
• beclomethasone nasal steroid spray (BECLOVENT, BECONASE AQ, VANCENASE AQ, VANCERIL); budesonide (RHINOCORT AQUA); fluticasone nasal steroid spray (FLONASE); mometasone nasal steroid spray (NASONEX); triamcinolone nasal steroid spray (NASACORT AQ)
• albuterol (PROVENTIL, VENTOLIN); pirbuterol (MAXAIR)
• fluticasone and salmeterol inhalation powders (ADVAIR DISKUS)
• salmeterol (SEREVENT)
• isoetharine (BETA-2, BRONKOMETER, BRONKOSOL)
• aluminum hydroxide (AMPHOJEL); aluminum hydroxide and magnesium carbonate (GAVISCON, GAVISCON-2); aluminum hydroxide and magnesium hydroxide (MAALOX, MAALOX TC); magaldrate (RIOPAN); magnesium hydroxide (FAMILY DOLLAR MILK OF MAGNESIA, PHILLIPS’ MILK OF MAGNESIA)
• aminophylline (AMOLINE, SOMOPHYLLIN, SOMOPHYLLIN-DF); theophylline (BRONKODYL, CONSTANT-T, ELIXOPHYLLIN, QUIBRON-T-SR, SLO-BID, SLO-PHYLLIN, SOMOPHYLLIN-CRT, SOMOPHYLLIN-T, SUSTAIRE, THEO-24, THEO-DUR, THEOLAIR, THEOLAIR-SR, UNIPHYL)
• cimetidine (TAGAMET); famotidine (PEPCID); nizatidine (AXID); ranitidine (ZANTAC)
• oxtriphylline (CHOLEDYL SA)
• beclomethasone inhaled steroid (QVAR AEROSOL); fluticasone inhaled steroid (FLOVENT, FLOVENT DISKUS, FLOVENT ROTADISK); triamcinolone inhalation (AZMACORT AEROSOL CANISTER)
• montelukast (SINGULAIR); zafirlukast (ACCOLATE)
• ipratropium (ATROVENT); ipratropium and albuterol (COMBIVENT)
• amoxicillin (AMOXIL); amoxicillin and clavulanate (AUGMENTIN); ampicillin (OMNIPEN)
• misoprostol (CYTOTEC)
• penicillin g; penicillin v (PEN VEE K)
• cefaclor (CECLOR); cefadroxil (DURICEF); cefditoren (SPECTRACEF); cefixime (SUPRAX); cefpodoxime (VANTIN); cefprozil (CEFZIL); cefuroxime axetil (CEFTIN); cephalexin (KEFLEX); cephradine (VELOSEF); loracarbef (LORABID)
• sucralfate (CARAFATE)
• erythromycin (EES, ERYTHROCIN)
• azithromycin (ZITHROMAX); clarithromycin (BIAXIN)
• erythromycin estolate (ILOSONE)
• telithromycin (KETEK)
• doxycycline (VIBRAMYCIN); minocycline (MINOCIN); tetracycline (ACHROMYCIN, PANMYCIN)
• sulfisoxazole (GANTRISIN); trimethoprim and sulfamethoxazole (BACTRIM, COTRIM, SEPTRA)
• gatifloxacin (TEQUIN); moxifloxacin (AVELOX); sparfloxacin (ZAGAM)
• alosetron (LOTRONEX)
• ciprofloxacin (CILOXAN, CIPRO); levofloxacin (LEVAQUIN); lomefloxacin (MAXAQUIN); ofloxacin (FLOXIN)
• norfloxacin (CHIBROXIN, NOROXIN)
• tegaserod (ZELNORM)
• trovafloxacin (TROVAN)
• prochlorperazine (COMPAZINE); promethazine (PHENERGAN)
• gemifloxacin (FACTIVE)
• trimethoprim (PROLOPRIM, TRIMPEX)
• clindamycin (CLEOCIN)
• metronidazole (FLAGYL)
• nitrofurantoin (FURADANTIN, MACROBID, MACRODANTIN)
• metoclopramide (REGLAN)
• trimethobenzamide (TIGAN)
• atropine, hyoscyamine, methenamine, methylene blue, phenyl salicylate and benzoic acid (URISED)
• chloramphenicol (CHLOROMYCETIN)
• isoniazid (INH)
• rifampin (RIFADIN, RIMACTANE)
• fluconazole (DIFLUCAN)
• itraconazole (SPORANOX); terbinafine (LAMISIL)
• terconazole (TERAZOL 3, TERAZOL 7)
• mebendazole (VERMOX)
• lindane (KWELL)
• amantadine (SYMMETREL)
• zanamivir (RELENZA)
• black cohosh (AWARENESS FEMALE BALANCE, ESTROVEN, REMIFEMIN)
• coenzyme q10 [co q 10, q10, vitamin q10, ubiquinone, ubidecarenone] (ANTI-AGING DAILY PREMIUM PAK, Q-GEL, VITAMIST INTRA-ORAL SPRAY)
• echinacea [purple coneflower, red sunflower, thimbleweed, rudbeckia] (HALLS DEFENSE MULTI-BLEND SUPPLEMENT DROPS)
• ephedra [ma huang, chinese ephedra, epitonin]
• garlic (KWAI, PHYTO-VITE)
• ginkgo biloba [maidenhair, EGb 761] (BIOLEAN FREE, CONCENTRATION, NEURO-BETIC, POWER CIRCULATION, SATIETE, STEPHAN CLARITY, STEPHAN ELIXIR, SUN-CARDO)
• ginseng (5 SENG TEA, DEXATRIM RESULTS, DIABETAN, GEROMATRIX GLUCOSE BALANCE, JIANG TANG PIAN, NATURE'S PLUS THE ENERGY SUPPLEMENTS, ONE-A-DAY ACTIVE DIETARY SUPPLEMENT, ONE-A-DAY ENERGY FORMULA, PHARMATON, POWER FRESH, UP YOUR GAS ENERGY BOOSTER)
• glucosamine and chondroitin (DONA, MAJESTIC EARTH)
• green tea
• milk thistle (MILK THISTLE HEALTH LIVER, RELIVE, THISILYN)
• saw palmetto [serenoa repens; serenoa serrulata; sabal serrulata] (ONE-A-DAY PROSTATE HEALTH, PERMIXON, POWER LASTING)
• St. John's wort [hypericum, goatweed, the lord god's wonder plant, witch's herb] (SUN BEAUTY)
• methylcellulose (CITRUCEL); psyllium (METAMUCIL, PERDIEM)
• lactulose (CEPHULAC, CHRONOLAC)
• bisacodyl (DULCOLAX); docusate (COLACE, SURFAK); docusate and casanthranol (DIALOSE PLUS, PERI-COLACE)
• loperamide (IMODIUM)
• diphenoxylate and atropine (LOMOTIL)
• atropine; atropine, hyoscyamine, scopolamine, and phenobarbital (DONNATAL); dicyclomine (BENTYL); hyoscyamine (LEVBID, LEVSIN)
• chlordiazepoxide and clidinium (LIBRAX)
• oseltamivir (TAMIFLU)
• pregabalin (LYRICA)